A cross-sectional study on the use of statin among patients with atherosclerotic ischemic stroke in China
Journal article
Jiang L. et al, (2010), Chin J Epidemiol, 31, 925 - 928
Cross-sectional study of statin use among high-risk patients with coronary heart disease in China
Journal article
Li J. et al, (2010), Chin Circ J, 25, 348 - 351
Survey of statin usage in 4429 diabetic patients with atherosclerostic cardiovascular disease in China
Journal article
Jiang L. et al, (2010), Chin J Cardiovasc Med, 15, 264 - 268
Greater absolute reductions in LDL cholesterol should yield greater proportional reductions in risk of cardiovascular disease.
Journal article
Clarke R. and Armitage J., (2009), J Intern Med, 266, 499 - 501
Aspirin for primary prevention of vascular disease in people with diabetes.
Journal article
Haynes R. et al, (2009), BMJ, 339
No Impact of KIF6 Genotype on Vascular Risk or Statin Benefit in the Heart Protection Study
Conference paper
Hopewell JC. et al, (2009), CIRCULATION, 120, S606 - S606
Effect of statins on atrial fibrillation: a collaborative meta-analysis of randomised controlled trials
Journal article
Rahimi K. et al, (2009), EUROPEAN HEART JOURNAL, 30, 450 - 451
Effect of statins on ventricular arrhythmic events: a collaborative meta-analysis of randomised controlled trials
Journal article
Rahimi K. et al, (2009), EUROPEAN HEART JOURNAL, 30, 591 - 591
Plasma phospholipid fatty acids and CHD in older men: Whitehall study of London civil servants.
Journal article
Clarke R. et al, (2009), Br J Nutr, 102, 279 - 284
Effects of simvastatin 40 mg daily on muscle and liver adverse effects in a 5-year randomized placebo-controlled trial in 20,536 high-risk people.
Journal article
MRC/BHF Heart Protection Study Collaborative Group None. et al, (2009), BMC Clin Pharmacol, 9
Statin cost-effectiveness in the United States for people at different vascular risk levels.
Journal article
Heart Protection Study Collaborative Group None., (2009), Circ Cardiovasc Qual Outcomes, 2, 65 - 72
Estimated 10-year cardiovascular risk in a British population: results of a national screening project.
Journal article
Neil HAW. et al, (2008), Int J Clin Pract, 62, 1322 - 1331
SLCO1B1 variants and statin-induced myopathy--a genomewide study.
Journal article
SEARCH Collaborative Group None. et al, (2008), N Engl J Med, 359, 789 - 799
Commentary on NICE technology appraisal guidance on ezetimibe for the treatment of primary (heterozygous-familial and non-familial) hypercholesterolaemia.
Journal article
Armitage J., (2008), Heart, 94, 643 - 645
Regarding "Does simvastatin save lives; If so, when and in whom?" - Reply
Journal article
Bulbulia R. et al, (2008), JOURNAL OF VASCULAR SURGERY, 47, 901 - 901
Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis.
Journal article
Cholesterol Treatment Trialists' (CTT) Collaborators None. et al, (2008), Lancet, 371, 117 - 125
The impact of privacy and confidentiality laws on the conduct of clinical trials.
Conference paper
Armitage J. et al, (2008), Clin Trials, 5, 70 - 74
Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths.
Journal article
Prospective Studies Collaboration None. et al, (2007), Lancet, 370, 1829 - 1839
The safety of statins in clinical practice.
Journal article
Armitage J., (2007), Lancet, 370, 1781 - 1790